259 related articles for article (PubMed ID: 17978591)
1. Lowering blood pressure with beta-blockers in combination with other renin-angiotensin system blockers in patients with hypertension and type 2 diabetes: results from the GEMINI Trial.
Wright JT; Bakris GL; Bell DS; Fonseca V; Katholi RE; McGill JB; Messerli FH; Phillips RA; Raskin P; Holdbrook FK; Lukas MA; Iyengar M
J Clin Hypertens (Greenwich); 2007 Nov; 9(11):842-9. PubMed ID: 17978591
[TBL] [Abstract][Full Text] [Related]
2. Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.
Bakris GL; Fonseca V; Katholi RE; McGill JB; Messerli FH; Phillips RA; Raskin P; Wright JT; Oakes R; Lukas MA; Anderson KM; Bell DS;
JAMA; 2004 Nov; 292(18):2227-36. PubMed ID: 15536109
[TBL] [Abstract][Full Text] [Related]
3. Beta-blockers have a beneficial effect upon endothelial function and microalbuminuria in African-American subjects with diabetes and hypertension.
Jawa A; Nachimuthu S; Pendergrass M; Asnani S; Fonseca V
J Diabetes Complications; 2008; 22(5):303-8. PubMed ID: 18413195
[TBL] [Abstract][Full Text] [Related]
4. Artist® tablets (carvedilol) for hypertensive patients in Japan: results of a drug use survey.
Mori Y; Nishikawa Y; Iizuka T; Zenimura N; Matsumoto T; Hiramatsu K; Komiya M
Drugs R D; 2011; 11(2):171-90. PubMed ID: 21679007
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of beta-blockers on albuminuria in patients with type 2 diabetes.
Bakris GL; Fonseca V; Katholi RE; McGill JB; Messerli F; Phillips RA; Raskin P; Wright JT; Waterhouse B; Lukas MA; Anderson KM; Bell DS;
Hypertension; 2005 Dec; 46(6):1309-15. PubMed ID: 16286578
[TBL] [Abstract][Full Text] [Related]
6. Comparison of carvedilol and metoprolol on serum lipid concentration in diabetic hypertensive patients.
Bell DS; Bakris GL; McGill JB
Diabetes Obes Metab; 2009 Mar; 11(3):234-8. PubMed ID: 18564334
[TBL] [Abstract][Full Text] [Related]
7. Demographic analyses of the effects of carvedilol vs metoprolol on glycemic control and insulin sensitivity in patients with type 2 diabetes and hypertension in the Glycemic Effects in Diabetes Mellitus: Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) study.
Phillips RA; Fonseca V; Katholi RE; McGill JB; Messerli FH; Bell DS; Raskin P; Wright JT; Iyengar M; Anderson KM; Lukas MA; Bakris GL;
J Cardiometab Syndr; 2008; 3(4):211-7. PubMed ID: 19040589
[TBL] [Abstract][Full Text] [Related]
8. beta-blocker use and diabetes symptom score: results from the GEMINI study.
McGill JB; Bakris GL; Fonseca V; Raskin P; Messerli FH; Phillips RA; Katholi RE; Wright JT; Iyengar M; Anderson KM; Lukas MA; Dalal MR; Bell DS
Diabetes Obes Metab; 2007 May; 9(3):408-17. PubMed ID: 17391169
[TBL] [Abstract][Full Text] [Related]
9. Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).
Di Lenarda A; Remme WJ; Charlesworth A; Cleland JG; Lutiger B; Metra M; Komajda M; Torp-Pedersen C; Scherhag A; Swedberg K; Poole-Wilson PA;
Eur J Heart Fail; 2005 Jun; 7(4):640-9. PubMed ID: 15921806
[TBL] [Abstract][Full Text] [Related]
10. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
Wong GW; Laugerotte A; Wright JM
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
[TBL] [Abstract][Full Text] [Related]
11. [Beta-adrenoceptor antagonists and ACE-inhibitors. Carvedilol compared with metoprolol as combination partner in cases of diabetes and hypertension].
Frese T; Sandholzer H
Dtsch Med Wochenschr; 2007 Nov; 132(44):2330-1. PubMed ID: 17957597
[TBL] [Abstract][Full Text] [Related]
12. Body weight changes with beta-blocker use: results from GEMINI.
Messerli FH; Bell DS; Fonseca V; Katholi RE; McGill JB; Phillips RA; Raskin P; Wright JT; Bangalore S; Holdbrook FK; Lukas MA; Anderson KM; Bakris GL;
Am J Med; 2007 Jul; 120(7):610-5. PubMed ID: 17602935
[TBL] [Abstract][Full Text] [Related]
13. Vasopressor response to angiotensin II infusion in patients with chronic heart failure receiving beta-blockers.
Vittorio TJ; Lang CC; Katz SD; Packer M; Mancini DM; Jorde UP
Circulation; 2003 Jan; 107(2):290-3. PubMed ID: 12538430
[TBL] [Abstract][Full Text] [Related]
14. Effects of nebivolol on aortic compliance in patients with diabetes and maximal renin angiotensin system blockade: the EFFORT study.
Briasoulis A; Oliva R; Kalaitzidis R; Flynn C; Lazich I; Schlaffer C; Bakris G
J Clin Hypertens (Greenwich); 2013 Jul; 15(7):473-9. PubMed ID: 23815535
[TBL] [Abstract][Full Text] [Related]
15. [Antihypertensive activity and effect on parameters of heart rate variability of beta-blockers carvedilol and metoprolol].
Praskurnichiĭ EA; Shevchenko OP; Makarova SV; Zhukova VA
Kardiologiia; 2005; 45(11):17-23. PubMed ID: 16353059
[No Abstract] [Full Text] [Related]
16. Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10-Year Cohort.
Tang CH; Wang CC; Chen TH; Hong CY; Sue YM
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26738790
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of beta-blocker therapy with metoprolol or with carvedilol for treatment of heart failure in Canada.
Levy AR; Briggs AH; Demers C; O'Brien BJ
Am Heart J; 2001 Sep; 142(3):537-43. PubMed ID: 11526370
[TBL] [Abstract][Full Text] [Related]
18. Beta-blockade in heart failure: a comparison of carvedilol with metoprolol.
Sanderson JE; Chan SK; Yip G; Yeung LY; Chan KW; Raymond K; Woo KS
J Am Coll Cardiol; 1999 Nov; 34(5):1522-8. PubMed ID: 10551702
[TBL] [Abstract][Full Text] [Related]
19. Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol.
Metra M; Nodari S; D'Aloia A; Muneretto C; Robertson AD; Bristow MR; Dei Cas L
J Am Coll Cardiol; 2002 Oct; 40(7):1248-58. PubMed ID: 12383572
[TBL] [Abstract][Full Text] [Related]
20. Tolerability of beta-blockers in outpatients with refractory heart failure who were receiving continuous milrinone.
Earl GL; Verbos-Kazanas MA; Fitzpatrick JM; Narula J
Pharmacotherapy; 2007 May; 27(5):697-706. PubMed ID: 17461705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
